| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,809 |
11,374 |
$1.01M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,449 |
3,341 |
$417K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,054 |
2,877 |
$342K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
7,790 |
7,493 |
$286K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,295 |
2,199 |
$285K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,714 |
1,669 |
$190K |
| 97802 |
|
4,792 |
4,622 |
$114K |
| 90461 |
|
3,761 |
3,648 |
$96K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
717 |
706 |
$84K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
428 |
399 |
$21K |
| 99188 |
|
1,067 |
1,030 |
$17K |
| 85018 |
|
6,697 |
6,490 |
$12K |
| 87428 |
|
264 |
252 |
$10K |
| 99051 |
|
587 |
570 |
$6K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
45 |
42 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
435 |
230 |
$5K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
735 |
704 |
$5K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
2,675 |
2,508 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
148 |
146 |
$4K |
| 90648 |
|
1,842 |
1,779 |
$3K |
| 90686 |
|
1,449 |
1,376 |
$3K |
| 90670 |
|
1,524 |
1,466 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
209 |
203 |
$3K |
| 96127 |
|
688 |
657 |
$3K |
| 90716 |
|
595 |
573 |
$2K |
| 0072A |
|
49 |
49 |
$2K |
| 91300 |
|
124 |
122 |
$2K |
| 0071A |
|
50 |
39 |
$1K |
| 90633 |
|
913 |
872 |
$1K |
| 0002A |
|
53 |
53 |
$1K |
| 90707 |
|
559 |
541 |
$1K |
| 0001A |
|
47 |
47 |
$1K |
| 90696 |
|
106 |
105 |
$424.72 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
45 |
37 |
$350.78 |
| 99173 |
|
3,304 |
2,858 |
$289.63 |
| 90710 |
|
43 |
42 |
$270.16 |
| 81002 |
|
92 |
87 |
$240.50 |
| 90656 |
|
65 |
65 |
$209.22 |
| 90681 |
|
43 |
43 |
$200.00 |
| 90723 |
|
1,242 |
1,212 |
$147.01 |
| 96161 |
|
59 |
57 |
$96.48 |
| 90680 |
|
902 |
875 |
$96.02 |
| 90700 |
|
72 |
67 |
$51.60 |
| 36416 |
|
5,461 |
4,896 |
$42.92 |
| 90651 |
|
191 |
189 |
$24.01 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
29 |
25 |
$17.29 |
| 94760 |
|
29 |
24 |
$2.50 |
| 91307 |
|
147 |
118 |
$0.39 |
| 90671 |
|
176 |
176 |
$0.03 |
| 90677 |
|
15 |
15 |
$0.01 |
| 90734 |
|
118 |
116 |
$0.00 |
| 99177 |
|
319 |
302 |
$0.00 |
| 90715 |
|
42 |
42 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
214 |
202 |
$0.00 |